Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy-Reference-Cited by-同舟云学术

Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy

Published:2016-07 Issue:1 Volume:120 Page:128-135
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Heethuis Sophie E.,van Rossum Peter S.N.,Lips Irene M.,Goense Lucas,Voncken Francine E.,Reerink Onne,van Hillegersberg Richard,Ruurda Jelle P.,Philippens Marielle E.,van Vulpen Marco,Meijer Gert J.,Lagendijk Jan J.W.,van Lier Astrid L.H.M.W.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference40 articles.

1. Global cancer statistics, 2012;Torre;CA: A Cancer J Clin,2015

2. Oesophageal carcinoma;Pennathur;Lancet,2013

3. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med,2012

4. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial;Omloo;Ann Surg,2007

5. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis;Sjoquist;Lancet Oncol,2011

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of pretreatment radiological MRI variables and dynamic contrast-enhanced MRI on radiotherapy treatment outcome in laryngeal and hypopharyngeal tumors;Clinical and Translational Radiation Oncology;2024-09

2. Radiomics in Oesogastric Cancer: Staging and Prediction of Preoperative Treatment Response: A Narrative Review and the Results of Personal Experience;Cancers;2024-07-26

3. Early Contrast-Enhanced MR for Diagnosing Complete Tumor Response of Locally Advanced Esophageal Squamous Cell Carcinoma After Neoadjuvant Therapy: A Retrospective Comparative Study;Annals of Surgical Oncology;2024-03-07

4. Baseline and interim [18F]FDG-PET/MRI to assess treatment response and survival in patients with M0 esophageal squamous cell carcinoma treated by curative-intent therapy;Cancer Imaging;2023-11-06

5. Complete responses after neoadjuvant toripalimab and chemoradiotherapy for oesophageal squamous cell carcinoma: in situ and ex vivo 3.0 T MRI assessment;British Journal of Surgery;2023-11-01